Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mugen Ujiie"'
Autor:
Osamu Matsuoka, Mugen Ujiie, Hitoshi Kikuchi, Sachiko Otake, Danaya Chansinghakul, Takahiro Inoue, Kucku Varghese, Nuchra Sirisuphmitr, Tomoyuki Hashiguchi, Betzana Zambrano, Takahiro Nakama, Carina Frago, Emilia Jordanov, Mandeep Singh Dhingra
Publikováno v:
Japanese Journal of Infectious Diseases. 76:174-182
Autor:
Makoto Inada, Sho Saito, Shinya Tsuzuki, Nobumasa Okumura, Lubna Sato, Kohei Kamegai, Mio Sanada, Mika Komatsubara, Masayuki Shimojima, Hideki Ebihara, Fumi Kasuya, Mami Nagashima, Kenji Sadamasu, Kei Yamamoto, Mugen Ujiie, Shinichiro Morioka, Norio Ohmagari
Publikováno v:
Journal of Infection and Chemotherapy. 29:418-421
Autor:
Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, Noriko Iwamoto, Mugen Ujiie, Satoshi Kutsuna, Shinichiro Morioka, Yukihito Ishizaka, Hiroaki Mitsuya, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases. 119:18-20
Autor:
Shinya Tsuzuki, Tetsuya Suzuki, Mugen Ujiie, Masayuki Ota, Michiyo Suzuki, Kei Yamamoto, Hidetoshi Nomoto, Sho Saito, Akatsuki Kokaze, Noriko Kinoshita
Publikováno v:
Japanese Journal of Infectious Diseases. 74:399-404
Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is generally used for booster vaccination of infants in Europe and the United States to avoid increased reactogenicity after diphtheria and tetanus toxoids and acellula
Autor:
Taketomo Maruki, Noriko Iwamoto, Kohei Kanda, Nobumasa Okumura, Gen Yamada, Masahiro Ishikane, Mugen Ujiie, Masumichi Saito, Tsuguto Fujimoto, Tsutomu Kageyama, Tomoya Saito, Shinji Saito, Tadaki Suzuki, Norio Ohmagari
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
In November 2021, the World Health Organization designated a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern, Omicron (PANGO lineage B.1.1.529). We report on the first 2 cases of breakthrough coronavirus disease 20
Autor:
Harutaka Katano, Mugen Ujiie, Taketomo Maruki, Norio Ohmagari, Masahiro Ishikane, Tetsuya Suzuki
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss, Pp 55-57 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
We report a case of varicella zoster virus (VZV) meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient. A final diagnosis was made based on identification of VSV via positive polymerase chain reaction of cerebrospinal
Autor:
Kenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie, Noriko Iwamoto, Nobumasa Okumura, Testsuro Sato, Maki Nagashima, Ataru Moriya, Michiyo Suzuki, Masayuki Hojo, Takayuki Kanno, Shinji Saito, Sho Miyamoto, Akira Ainai, Minoru Tobiume, Takeshi Arashiro, Tsuguto Fujimoto, Tomoya Saito, Masaya Yamato, Tadaki Suzuki, Norio Ohmagari
Publikováno v:
Emerging infectious diseases. 28(5)
To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vac
Autor:
Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura, Katsushi Tokunaga
Publikováno v:
Vaccines; Volume 10; Issue 4; Pages: 563
BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech, New York, NY, USA), is one of the most effective COVID-19 vaccines and has been approved by more than 130 countries worldwide. However, several studies have reported that the COVID-19 vacci
Autor:
Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Shin-ichiro Hattori, Junko S. Takeuchi, Tomoya Saito, Mugen Ujiie, Masayuki Hojo, Noriko Iwamoto, Wataru Sugiura, Hiroaki Mitsuya, Norio Ohmagari
Publikováno v:
Journal of infection and chemotherapy
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy
The Omicron variant of severe acute respiratory syndrome coronavirus 2 has multiple amino acid mutations in its spike proteins, which may allow it to evade immunity elicited by vaccination. We examined the neutralising activity and S1-IgG titres in p
Autor:
Yuzo Arima, Satoshi Kutsuna, Tomoe Shimada, Motoi Suzuki, Tadaki Suzuki, Yusuke Kobayashi, Yuuki Tsuchihashi, Haruna Nakamura, Kaoru Matsumoto, Asuka Takeda, Keisuke Kadokura, Tetsuro Sato, Yuichiro Yahata, Noriko Nakajima, Minoru Tobiume, Ikuyo Takayama, Tsutomu Kageyama, Shinji Saito, Naganori Nao, Tamano Matsui, Tomimasa Sunagawa, Hideki Hasegawa, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Tetsuya Suzuki, Satoshi Ide, Keiji Nakamura, Yuki Moriyama, Noriko Kinoshita, Yutaro Akiyama, Yusuke Miyazato, Hidetoshi Nomoto, Takato Nakamoto, Masayuki Ota, Sho Saito, Masahiro Ishikane, Shinichiro Morioka, Kei Yamamoto, Mugen Ujiie, Mari Terada, Haruhito Sugiyama, Norihiro Kokudo, Norio Ohmagari, Makoto Ohnishi, Takaji Wakita
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 7, Pp 1596-1600 (2020)
Emerging Infectious Diseases
Emerging Infectious Diseases
In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and 14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome coronavirus 2 infection; initial screening results were negative for 5.